688105 fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Nanjing Vazyme Biotech Co., Ltd. engages in the research and development, and production of antibody drugs. Its products include Biological reagents and In vitro diagnostic products. The biological reagents products consist of polymerase chain reaction series, molecular cloning series, reverse record series, gene sequencing series, bio-assay series, and cell and protein series. The In vitro diagnostic products encompass point-of-care testing diagnostic reagents and instrument. The company was founded on March 16, 2012 and is headquartered in Nanjing, China.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
No dividends
688105 has never paid dividends and has no current plans to do so.
Financial health
Financial position and solvency of the company